World Leader in

Cell Expansion & Rejuvenation

What
We do

EnhanceTM
Platform

Proprietary hematopoietic stem cell (HSC) expansion and rejuvenation platform

Learn more

UM171 Cell
Therapy

Allogeneic stem cell therapy to treat blood cancers

Learn more

Pipeline

Pre-clinical pipeline for blood cancers and other diseases

Learn more

News

March 25, 2025

ExCellThera announces new UM171 presentation on advances in stem cell transplant at the EBMT Annual Meeting

Dr. Guy Sauvageau, Chief Scientific Officer at ExCellThera will present on improving stem cell quality with UM171 for better transplant outcome MONTREAL, March 25, 2025 – ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, announced today that Dr. Guy Sauvageau, the company’s Chief Scientific Officer, will present on significant […]

Read more
See all articles

About us

Who we are

ExCellThera is an advanced clinical-stage company specializing in cell expansion and engineering, providing molecules and bioengineering solutions to expand and modify various cell lines for use in innovative single-use curative therapies for patients with hematological malignancies and other diseases.

Learn more
Symbol